54.50
price up icon0.94%   0.51
after-market 시간 외 거래: 54.50
loading
전일 마감가:
$53.99
열려 있는:
$54.77
하루 거래량:
1.80M
Relative Volume:
0.76
시가총액:
$136.64B
수익:
$52.07B
순이익/손실:
$6.25B
주가수익비율:
21.81
EPS:
2.4983
순현금흐름:
$9.91B
1주 성능:
+2.16%
1개월 성능:
+12.49%
6개월 성능:
+1.81%
1년 성능:
+19.00%
1일 변동 폭
Value
$54.05
$54.77
1주일 범위
Value
$53.20
$55.04
52주 변동 폭
Value
$45.22
$58.97

사노피 ADR Stock (SNY) Company Profile

Name
명칭
Sanofi Adr
Name
전화
-
Name
주소
-
Name
직원
82,878
Name
트위터
@sanofi
Name
다음 수익 날짜
2024-10-25
Name
최신 SEC 제출 서류
Name
SNY's Discussions on Twitter

SNY을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - General icon
SNY
Sanofi Adr
54.50 136.64B 52.07B 6.25B 9.91B 2.4983
Drug Manufacturers - General icon
LLY
Lilly Eli Co
844.27 802.40B 45.04B 10.59B -2.28B 11.71
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
77.87 345.67B 42.09B 14.65B 10.11B 3.2833
Drug Manufacturers - General icon
JNJ
Johnson Johnson
156.15 344.63B 88.82B 14.07B 18.06B 5.79
Drug Manufacturers - General icon
ABBV
Abbvie Inc
192.87 340.83B 56.33B 4.28B 15.62B 2.40
Drug Manufacturers - General icon
MRK
Merck Co Inc
83.01 251.88B 64.17B 17.12B 14.84B 6.7297

사노피 ADR Stock (SNY) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-01-30 업그레이드 Deutsche Bank Sell → Hold
2024-07-26 재확인 Argus Buy
2024-01-23 개시 Morgan Stanley Equal-Weight
2024-01-16 재개 UBS Buy
2023-12-05 다운그레이드 JP Morgan Overweight → Neutral
2023-10-30 다운그레이드 Stifel Buy → Hold
2023-09-06 업그레이드 Berenberg Hold → Buy
2023-07-14 개시 HSBC Securities Buy
2023-04-28 다운그레이드 Deutsche Bank Hold → Sell
2023-03-27 업그레이드 Barclays Equal Weight → Overweight
2022-12-13 재개 Morgan Stanley Overweight
2022-08-12 업그레이드 Deutsche Bank Sell → Hold
2022-08-09 다운그레이드 UBS Buy → Neutral
2022-05-23 개시 SVB Leerink Outperform
2021-09-27 업그레이드 SVB Leerink Mkt Perform → Outperform
2021-01-15 개시 Deutsche Bank Sell
2020-09-29 개시 Berenberg Hold
2020-03-17 업그레이드 Barclays Underweight → Equal Weight
2020-03-11 업그레이드 Goldman Neutral → Buy
2020-02-11 개시 SVB Leerink Mkt Perform
2020-01-06 업그레이드 JP Morgan Neutral → Overweight
2019-09-23 업그레이드 Guggenheim Neutral → Buy
2019-09-20 업그레이드 Morgan Stanley Equal-Weight → Overweight
2019-09-03 개시 Bernstein Outperform
2019-08-14 업그레이드 UBS Neutral → Buy
2018-12-11 업그레이드 Jefferies Hold → Buy
2018-11-01 업그레이드 Barclays Underweight → Equal Weight
2018-10-09 개시 Guggenheim Neutral
2018-09-10 업그레이드 BofA/Merrill Neutral → Buy
2018-08-10 업그레이드 Citigroup Neutral → Buy
2018-03-23 업그레이드 Liberum Hold → Buy
2018-01-23 다운그레이드 Barclays Equal Weight → Underweight
2017-12-06 다운그레이드 BofA/Merrill Buy → Neutral
2017-12-01 다운그레이드 Morgan Stanley Overweight → Underweight
2017-11-15 업그레이드 Barclays Underweight → Equal Weight
2017-08-30 업그레이드 HSBC Securities Reduce → Hold
모두보기

사노피 ADR 주식(SNY)의 최신 뉴스

pulisher
Feb 14, 2025

Harrow Earns Relative Strength Rating Upgrade - Inkl

Feb 14, 2025
pulisher
Feb 13, 2025

Respiratory Syncytial Virus Therapeutics Market to Hit USD 4.64 Billion by 2032, Growing at a 14.5% CAGR – SNS Insider - GlobeNewswire Inc.

Feb 13, 2025
pulisher
Feb 13, 2025

Sanofi ADR Earns RS Rating Upgrade - Investor's Business Daily

Feb 13, 2025
pulisher
Feb 07, 2025

What was Skechers U S A, Inc (SKX)’s performance in the last session? - US Post News

Feb 07, 2025
pulisher
Feb 07, 2025

Sanofi ADR (SNY) requires closer examination - US Post News

Feb 07, 2025
pulisher
Feb 05, 2025

Sanofi ADR (SNY): A Technical Analysis - The News Heater

Feb 05, 2025
pulisher
Feb 05, 2025

GNPX’s Market Whiplash: -38.94% YTD Decline, -42.28% Plunge in 30 Days - The InvestChronicle

Feb 05, 2025
pulisher
Feb 05, 2025

Applied Materials Inc’s Banking’s 100-Day Moving Average at 182.60: Will the Stock Break Through? - The InvestChronicle

Feb 05, 2025
pulisher
Feb 05, 2025

ESPR’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Feb 05, 2025
pulisher
Feb 04, 2025

Regeneron Pharmaceuticals Beats On Libtayo's Back, Unveils Dividend - Investor's Business Daily

Feb 04, 2025
pulisher
Feb 03, 2025

Waltham biotech plans to raise $150M in IPO this week - The Business Journals

Feb 03, 2025
pulisher
Jan 30, 2025

Sanofi Reports Strong Q4 Sales Growth, Plans €5 Billion Buyback in 2025 - GuruFocus.com

Jan 30, 2025
pulisher
Jan 30, 2025

Sanofi ADR earnings beat by $0.53, revenue fell short of estimates - Investing.com South Africa

Jan 30, 2025
pulisher
Jan 30, 2025

Sanofi ADR (SNY) Recovers 15.33% From Low: Are We There Yet? - Stocks Register

Jan 30, 2025
pulisher
Jan 29, 2025

Sanofi: Informations relatives au nombre de droits de vote et d'actions - GlobeNewswire Inc.

Jan 29, 2025
pulisher
Jan 27, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Jan 27, 2025
pulisher
Jan 25, 2025

AECOM (NYSE: ACM) Is A Blank Check For Growth - Stocks Register

Jan 25, 2025
pulisher
Jan 25, 2025

Shares Of Pennymac Mortgage Investment Trust (NYSE: PMT): Are They Overvalued Compared To Others? - Stocks Register

Jan 25, 2025
pulisher
Jan 17, 2025

7MM Type 1 Diabetes Market Drug Forecast and Market Analysis 2023-2024 & 2033: Value to Reach $9.91 Billion - GlobeNewswire Inc.

Jan 17, 2025
pulisher
Dec 23, 2024

Gsk Plc ADR (GSK-N) QuotePress Release - The Globe and Mail

Dec 23, 2024
pulisher
Dec 23, 2024

3 Pharma Stocks To Buy As California Sounds The Alarm On Bird Flu Cases - Barchart

Dec 23, 2024
pulisher
Dec 19, 2024

Communiqué de presse - GlobeNewswire Inc.

Dec 19, 2024
pulisher
Dec 18, 2024

Teva Pharmaceutical ADR Clears Technical Benchmark, Hitting 90-Plus RS Rating - Investor's Business Daily

Dec 18, 2024
pulisher
Dec 18, 2024

10 Best Blue-Chip Stocks to Buy for the Long Term - Morningstar

Dec 18, 2024
pulisher
Dec 17, 2024

Teva Catapults 26%, Hitting A Six-Year High, After Scoring A Win With Sanofi-Tied Drug - Investor's Business Daily

Dec 17, 2024
pulisher
Dec 17, 2024

What Did We Find About Insider Trading At Sanofi ADR (NASDAQ: SNY)? - Stocks Register

Dec 17, 2024
pulisher
Dec 16, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Dec 16, 2024
pulisher
Dec 12, 2024

Upcoming Nasdaq-100 changes could boost the stocks of these 11 companies - MSN

Dec 12, 2024

사노피 ADR (SNY) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$104.08
price down icon 1.77%
drug_manufacturers_general PFE
$25.53
price down icon 0.43%
$291.16
price down icon 1.96%
drug_manufacturers_general NVS
$105.43
price down icon 2.12%
drug_manufacturers_general MRK
$83.01
price down icon 1.67%
자본화:     |  볼륨(24시간):